On June 11, 2024, Crown Electrokinetics Was Informed By Letter That Its Request For Continued Listing On Nasdaq Was Approved By The Panel, With The Condition That Company Must Comply With All Applicable Criteria For Continued Listing On The Nasdaq Capital Market By July 23, 2024, Among Other Interim Conditions.
Portfolio Pulse from Benzinga Newsdesk
Crown Electrokinetics (CRKN) has received approval from Nasdaq for continued listing, contingent on meeting all applicable criteria by July 23, 2024.
June 11, 2024 | 8:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Crown Electrokinetics has been approved for continued listing on Nasdaq, provided it meets all applicable criteria by July 23, 2024.
The approval for continued listing on Nasdaq is a positive development for Crown Electrokinetics, as it ensures the company remains on a major exchange, which can boost investor confidence and potentially lead to a short-term increase in stock price. However, the company must meet all applicable criteria by July 23, 2024, which introduces some uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100